Singapore Paincare Holdings (Catalist:FRQ) - Aandelenkoers, Nieuws & Analyse

FRQ Overzicht aandelen

Singapore Paincare Holdings Limited, een beleggingsholding, exploiteert medische klinieken in Singapore.

FRQ fundamentele analyse
Sneeuwvlok Score
Waardering	4/6
Toekomstige groei	0/6
Prestaties in het verleden	2/6
Financiële gezondheid	6/6
Dividenden	0/6

Beloningen

Trading at 55.4% below our estimate of its fair value

Became profitable this year

Risicoanalyse

Shares are highly illiquid

Earnings have declined by 10.6% per year over past 5 years

Does not have a meaningful market cap (SGD21M)

Singapore Paincare Holdings Limited Concurrenten

Alliance Healthcare Group

Catalist:MIJ

S$26.8m

Niks Professional

Catalist:NPL

S$17.9m

AsiaMedic

Catalist:505

S$12.7m

Medinex

Catalist:OTX

S$26.5m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Singapore Paincare Holdings
Historische aandelenkoersen
Huidige aandelenkoers	S$0.12
52 Week Hoogtepunt	S$0.20
52 Week Laag	S$0.11
Bèta	0.31
11 maand verandering	0%
3 maanden verandering	-7.69%
1 Jaar Verandering	-40.00%
33 jaar verandering	-36.51%
5 jaar verandering	n/a
Verandering sinds IPO	-42.86%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	FRQ	SG Healthcare	SG Markt
7D	4.3%	-1.1%	-1.0%
1Y	-40.0%	-15.5%	10.1%

Rendement versus industrie: FRQ underperformed the SG Healthcare industry which returned -15.5% over the past year.

Rendement versus markt: FRQ underperformed the SG Market which returned 10.1% over the past year.

Prijsvolatiliteit

Is FRQ's price volatile compared to industry and market?
FRQ volatility
FRQ Average Weekly Movement	n/a
Healthcare Industry Average Movement	5.7%
Market Average Movement	5.0%
10% most volatile stocks in SG Market	15.1%
10% least volatile stocks in SG Market	2.4%

Stabiele aandelenkoers: FRQ's share price has been volatile over the past 3 months compared to the SG market.

Volatiliteit in de loop van de tijd: Insufficient data to determine FRQ's volatility change over the past year.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2007	105	Bernard Lee	www.sgpaincareholdings.com

Singapore Paincare Holdings Limited, een beleggingsholding, exploiteert medische klinieken in Singapore. Het biedt pijnbestrijdingsdiensten voor de behandeling van patiënten met acute en chronische pijn, waaronder minimaal invasieve procedures, kankerpijntherapie, farmacotherapie en cognitieve gedragstherapie, evenals nekpijn, lage rugpijn, wervelkanaalstenose, artrose, fibromyalgie, frozen shoulder, fasciitis plantaris en tenniselleboog; en eerstelijnszorg en andere diensten, waaronder algemene medische consulten, beheer van chronische en acute aandoeningen en dermatologische diensten. Het bedrijf biedt ook myofasciale pijninjecties, platelet rich plasma, neuroplastie, necleoplastie, radiofrequentieablatie, intrathecale pompimplantaten, gepulseerde radiofrequentie, ruggenmergstimulator, ketaminetherapie en endoscopische laserdecompressiediensten.

Singapore Paincare Holdings Limited Samenvatting

Hoe verhouden de winst en inkomsten van Singapore Paincare Holdings zich tot de beurswaarde?
FRQ fundamentele statistieken
Marktkapitalisatie	S$20.52m
Inkomsten(TTM)	S$1.97m
Inkomsten(TTM)	S$27.49m

10.4x

Koers/Winstverhouding

0.7x

P/S-verhouding

Is FRQ overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
FRQ resultatenrekening (TTM)
Inkomsten	S$27.49m
Kosten van inkomsten	S$17.87m
Brutowinst	S$9.62m
Overige uitgaven	S$7.66m
Inkomsten	S$1.97m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	0.011
Brutomarge	35.00%
Nettowinstmarge	7.15%
Schuld/Eigen Vermogen Verhouding	16.2%

Hoe presteerde FRQ op de lange termijn?

Bekijk historische prestaties en vergelijking

FRQ Overzicht aandelen

Beloningen

Risicoanalyse

Singapore Paincare Holdings Limited Concurrenten

Catalist:MIJ

S$26.8m

Catalist:NPL

S$17.9m

Catalist:505

S$12.7m

Catalist:OTX

S$26.5m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Full year 2024 earnings released: EPS: S$0.011 (vs S$0.004 loss in FY 2023)

Singapore Paincare Holdings Limited, Annual General Meeting, Oct 25, 2024

Singapore Paincare Holdings Limited Announces Changes to the Composition of the Board

Full year 2024 earnings released: EPS: S$0.012 (vs S$0.003 loss in FY 2023)

Singapore Paincare Holdings Limited Appoints Isaac Peh Lin Siah as Financial Controller, Effective August 22, 2024

New minor risk - Dividend sustainability

Recent updates

Full year 2024 earnings released: EPS: S$0.011 (vs S$0.004 loss in FY 2023)

Singapore Paincare Holdings Limited, Annual General Meeting, Oct 25, 2024

Singapore Paincare Holdings Limited Announces Changes to the Composition of the Board

Full year 2024 earnings released: EPS: S$0.012 (vs S$0.003 loss in FY 2023)

Singapore Paincare Holdings Limited Appoints Isaac Peh Lin Siah as Financial Controller, Effective August 22, 2024

New minor risk - Dividend sustainability

Now 23% undervalued

High number of new directors

Singapore Paincare Holdings Limited Announces the Appointment of Soh Chiong Siong as Financial Controller, Effective April 22, 2024

Insufficient new directors

Now 22% undervalued after recent price drop

Singapore Paincare Holdings Limited Announces Yap Beng Tat, Richard Resigns as Independent Non-Executive Director

Singapore Paincare Holdings Limited Announces Resignation of Lim Mong Ai, Karen as Financial Controller

Now 20% undervalued

Singapore Paincare Holdings Limited Proposes Final Dividend (Tax Exempt One-Tier) for the Financial Year Ended 30 June 2023, Payable on November 17, 2023

Full year 2023 earnings released: S$0.003 loss per share (vs S$0.022 profit in FY 2022)

Singapore Paincare Holdings Limited Proposes Final Dividend (Tax Exempt One-Tier) for the Financial Year Ended 30 June 2023

Singapore Paincare Holdings Limited, Annual General Meeting, Oct 27, 2023

Full year 2023 earnings released: S$0.003 loss per share (vs S$0.022 profit in FY 2022)

Singapore Paincare Holdings Limited to Report Fiscal Year 2023 Results on Aug 29, 2023

New minor risk - Financial data availability

Singapore Paincare Holdings Limited Appoints Lim Mong Ai, Karen as Financial Controller, Effective July 1, 2023

First half 2023 earnings released

Singapore Paincare Holdings Limited Appoints Lim Kah Meng as Chairman of the Remuneration Committee and A Member of the Audit Committee and the Nominating Committee

Upcoming dividend of S$0.012 per share

Singapore Paincare Holdings Limited Approves Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 30 June 2022

Full year 2022 earnings released: EPS: S$0.022 (vs S$0.013 in FY 2021)

Singapore Paincare Holdings Limited Announces Cessation of Chong Weng Hoe as Independent Non-Executive Director, Chairman of Remuneration Committee and Member of the Audit Committee and Nominating Committee

Full year 2022 earnings released: EPS: S$0.022 (vs S$0.013 in FY 2021)

Singapore Paincare Holdings Limited Recommends Final Dividend

Singapore Paincare Holdings Limited Announces Promotion of Leow Yong Kin from Financial Controller to Chief Financial Officer

High number of new and inexperienced directors

High number of new and inexperienced directors

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: EPS S$0.013 (vs S$0.031 in FY 2020)

Full year 2021 earnings released: EPS S$0.013 (vs S$0.031 in FY 2020)

Singapore Paincare Holdings Limited Appoints Dr. Lim Kah Meng as Independent Non-Executive Director

First half 2021 earnings released: EPS S$0.004 (vs S$0.01 in 1H 2020)

Singapore Paincare Holdings Limited (Catalist:FRQ) completed the acquisition of 40% stake in KCS Anaesthesia Services Pte. Ltd from Kong Chee Sang.

New 90-day high: S$0.23

Singapore Paincare Holdings Limited (Catalist:FRQ) agreed to acquire 40% stake in Kong Chee Seng fro SGD 2.4 million.

Singapore Paincare Holdings Limited has completed a Follow-on Equity Offering in the amount of SGD 3.96 million.

Full year earnings released - EPS S$0.031

Singapore Paincare Holdings Limited (Catalist:FRQ) entered into agreement to acquire AE Medical Sengkang Private Limited from Wong Shing Yip for SGD 0.17 million.

Singapore Paincare Holdings Limited has completed an IPO in the amount of SGD 5.33412 million.